Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

Trial Profile

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AVB-114 (Primary)
  • Indications Rectal fistula
  • Focus Therapeutic Use
  • Acronyms STOMP-II; STOMP2
  • Sponsors Avobis Bio

Most Recent Events

  • 29 Jan 2026 Results presented in an Avobis Bio media release Media Release.
  • 29 Jan 2026 According to an Avobis Bio media release, data from this study to be presented in an oral presentation at the upcoming European Crohn's and Colitis Organisation (ECCO) Congress.
  • 29 Oct 2025 According to Avobis Bio LLC media release, results from this trial were at a plenary session of the American College of Gastroenterology's Annual Scientific Meeting. The trial results were accepted as a late-breaking abstract and presented by Dr David A Schwartz, a STOMP2 investigator, Professor of Medicine in the Division of Gastroenterology, Hepatology and Nutrition, and Department of Medicine, and Director of the Inflammatory Bowel Disease Center at Vanderbilt University Medical Center.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top